Acute hyperviscosity: Syndromes and management

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Plasma hyperviscosity is a rare complication of both monoclonal and polyclonal disorders associated with elevation of immunoglobulins. Asymptomatic patients with an elevation in the serum viscosity do not require plasma exchange, and the majority will have other indications for therapeutic intervention. For patients with hemorrhagic or central nervous system manifestations, plasma exchange is the therapy of choice and is relatively safe. Viscosity measurements are not required to initiate therapy if the index of suspicion is high and the clinical presentation is typical. However, patients should have a sample sent for confirmation of the diagnosis. Whole-blood hyperviscosity is seen in patients with extreme elevation of the red cell and white cell count. Phlebotomy of patients with primary and secondary elevation of the red cell count is a well-established therapy.

Original languageEnglish (US)
Pages (from-to)1379-1385
Number of pages7
JournalBlood
Volume132
Issue number13
DOIs
StatePublished - Sep 27 2018

Fingerprint

Plasmas
Cells
Plasma Exchange
Viscosity
Viscosity measurement
Neurology
Cell Count
Immunoglobulins
Blood
Phlebotomy
Therapeutics
Central Nervous System
Serum

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Acute hyperviscosity : Syndromes and management. / Gertz, Morie.

In: Blood, Vol. 132, No. 13, 27.09.2018, p. 1379-1385.

Research output: Contribution to journalReview article

Gertz, Morie. / Acute hyperviscosity : Syndromes and management. In: Blood. 2018 ; Vol. 132, No. 13. pp. 1379-1385.
@article{546abafee41d4447bb7c4f3d6d5b1d33,
title = "Acute hyperviscosity: Syndromes and management",
abstract = "Plasma hyperviscosity is a rare complication of both monoclonal and polyclonal disorders associated with elevation of immunoglobulins. Asymptomatic patients with an elevation in the serum viscosity do not require plasma exchange, and the majority will have other indications for therapeutic intervention. For patients with hemorrhagic or central nervous system manifestations, plasma exchange is the therapy of choice and is relatively safe. Viscosity measurements are not required to initiate therapy if the index of suspicion is high and the clinical presentation is typical. However, patients should have a sample sent for confirmation of the diagnosis. Whole-blood hyperviscosity is seen in patients with extreme elevation of the red cell and white cell count. Phlebotomy of patients with primary and secondary elevation of the red cell count is a well-established therapy.",
author = "Morie Gertz",
year = "2018",
month = "9",
day = "27",
doi = "10.1182/blood-2018-06-846816",
language = "English (US)",
volume = "132",
pages = "1379--1385",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "13",

}

TY - JOUR

T1 - Acute hyperviscosity

T2 - Syndromes and management

AU - Gertz, Morie

PY - 2018/9/27

Y1 - 2018/9/27

N2 - Plasma hyperviscosity is a rare complication of both monoclonal and polyclonal disorders associated with elevation of immunoglobulins. Asymptomatic patients with an elevation in the serum viscosity do not require plasma exchange, and the majority will have other indications for therapeutic intervention. For patients with hemorrhagic or central nervous system manifestations, plasma exchange is the therapy of choice and is relatively safe. Viscosity measurements are not required to initiate therapy if the index of suspicion is high and the clinical presentation is typical. However, patients should have a sample sent for confirmation of the diagnosis. Whole-blood hyperviscosity is seen in patients with extreme elevation of the red cell and white cell count. Phlebotomy of patients with primary and secondary elevation of the red cell count is a well-established therapy.

AB - Plasma hyperviscosity is a rare complication of both monoclonal and polyclonal disorders associated with elevation of immunoglobulins. Asymptomatic patients with an elevation in the serum viscosity do not require plasma exchange, and the majority will have other indications for therapeutic intervention. For patients with hemorrhagic or central nervous system manifestations, plasma exchange is the therapy of choice and is relatively safe. Viscosity measurements are not required to initiate therapy if the index of suspicion is high and the clinical presentation is typical. However, patients should have a sample sent for confirmation of the diagnosis. Whole-blood hyperviscosity is seen in patients with extreme elevation of the red cell and white cell count. Phlebotomy of patients with primary and secondary elevation of the red cell count is a well-established therapy.

UR - http://www.scopus.com/inward/record.url?scp=85053860126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053860126&partnerID=8YFLogxK

U2 - 10.1182/blood-2018-06-846816

DO - 10.1182/blood-2018-06-846816

M3 - Review article

C2 - 30104220

AN - SCOPUS:85053860126

VL - 132

SP - 1379

EP - 1385

JO - Blood

JF - Blood

SN - 0006-4971

IS - 13

ER -